Supplemental Figure 4 from Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas

Autor:	Helena A. Yu, Franziska Michor, Gregory J. Riely, Mark G. Kris, Marc Ladanyi, Paul K. Paik, Andrew J. Plodkowski, Sara A. Hayes, Afsheen N. Iqbal, Isabel R. Preeshagul, Linda S. Ahn, Khadeja A. Moses, Alex Makhnin, Arielle Elkrief
Rok vydání:	2023
DOI:	10.1158/1078-0432.22632962.v1
Popis:	Supplemental Figure 4. A. Median progression-free survival and B. Overall survival for patients enrolled in the acquired resistance study
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d58e9d9523326d1f9db1fbe06b7815 https://doi.org/10.1158/1078-0432.22632962.v1 Zobrazit plný text záznamu